Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Several weeks ago we did a webinar, co-sponsored with LUNGevity Foundation, with Dr. Mark Millard, pulmonologist at Baylor University in Dallas, TX, who provided a brief summary of tobacco's uptake in the US and worldwide, then covered the controversy over its association with lung cancer. These are the subject of the first podcast covering his webinar, and part two will cover current approaches to smoking cessation.
Here's the audio and video versions of the podcast, as well as the transcript and figures:
millard-on-tobacco-and-lung-cancer-audio-podcast
millard-on-tobacco-and-lung-cancer-transcript
millard-on-tobacco-and-lung-cancer-figures
We'll follow with the second part of his talk, which focused on cultural, behavioral, and pharmaceutical/medical interventions to help with smoking cessation in the next couple of weeks.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…